An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Cited by (690)

Items 201–300 of 690

1. Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways
   Wenjin Jim Zheng, Qing Xu, Yiyuan Zhang, E Xiaofei, Wei Gao, Mogen Zhang, Weijie Zhai, Ronaldjit Singh Rajkumar, Zhijun Liu · 2020 · Virology Journal
2. A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses
   Hongxing Hu, Jarrod Voss, Guoliang Zhang, Philippe Buchy, Teng Zuo, Lulan Wang, Feng Wang, Fan Zhou, Guiqing Wang, Cheguo Tsai et al. · 2012 · Journal of Virology
3. Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
   Daniel Voß, Susanne Pfefferle, Christian Drosten, Lea Stevermann, Elisabetta Traggiai, Antonio Lanzavecchia, Stephan Becker · 2009 · Virology Journal
4. Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options
   Mohammad Ridwane Mungroo, Naveed Ahmed Khan, Ruqaiyyah Siddiqui · 2020 · Pathogens
5. Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse®
   Coughlin, Melissa, Lou, Gin, Martinez, Osvaldo, Masterman, Stephanie K., Olsen, Ole A., Moksa, Angelica A., Farzan, Michael, Babcook, John S., Prabhakar, Bellur S. · 2007 · Virology
6. A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients
   Antonino Cassotta, Vincent Mikol, Thomas Bertrand, Stéphanie Pouzieux, Josiane Le Parc, Paul Ferrari, Jacques Dumas, Michael Auer, Florian Deisenhammer, Matteo Gastaldi et al. · 2019 · Nature Medicine
7. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview
   Manasik Gumah Ali, Zhening Zhang, Qi Gao, Mingzhu Pan, Edward G. Rowan, Juan Zhang · 2020 · Immunologic Research
8. Hydrated Silica Exterior Produced by Biomimetic Silicification Confers Viral Vaccine Heat-Resistance
   Guangchuan Wang, Hong-Jiang Wang, Hangyu Zhou, Qing-Gong Nian, Zhiyong Song, Yong‐Qiang Deng, Xiaoyu Wang, Shun-Ya Zhu, Xiao-Feng Li, Cheng‐Feng Qin et al. · 2015 · ACS Nano
9. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes
   Zhihua Kou, Joanne Y. H. Lim, Martina Beltramello, Matthew Quinn, Huiyuan Chen, Shengyo-ng Liu, Luis Martínez‐Sobrido, Michael Diamond, Jacob J. Schlesinger, Aravinda de Silva et al. · 2010 · Virology
10. Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics
    Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang · 2020 · Glycobiology
11. VAR2CSA and protective immunity against pregnancy-associatedPlasmodium falciparummalaria
    Lars Hviid, Ali Salanti · 2007 · Parasitology
12. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
    Anthony D. Cristillo, M. G. Ferrari, Lauren Hudacik, Brad Lewis, Lindsey Galmin, William S. Bowen, Darby J.S. Thompson, Nikolai Petrovsky, P D Markham, R Pal · 2010 · Journal of General Virology
13. Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
    Jianhua Sui, Meagan E. Deming, Barry Rockx, Robert Liddington, Quan Karen Zhu, Ralph Steven Baric, Wayne Anthony Marasco · 2014 · Journal of Virology
14. Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus
    Timothy Patrick Sheahan, Barry Rockx, Eric Donaldson, Davide Corti, Ralph Steven Baric · 2008 · Journal of Virology
15. Development of antiviral therapy for severe acute respiratory syndrome
    J CINATLJR, Martin Michaelis, Gerold Hoever, Wolfgang Preiser, Hans Wilhelm Doerr · 2005 · Antiviral Research
16. From SARS to MERS: evidence and speculation
    Hainv Gao, Hangping Yao, Shigui Yang, Lanjuan Li · 2016 · Frontiers of Medicine
17. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks
    Rupinder Mann, Abhilash Perisetti, Mahesh Gajendran, Zainab Gandhi, Chandraprakash Umapathy, Hemant Goyal · 2020 · Frontiers in Medicine
18. Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design
    James E. Crowe · 2017 · Cell Host & Microbe
19. Epstein–Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth
    Claire D Shannon-Lowe, Gouri Baldwin, Regina Feederle, Andrew Ian Bell, Alan B. Rickinson, Henri‐Jacques Delecluse · 2005 · Journal of General Virology
20. Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
    Saba Ismail, Sajjad Ahmad, Syed Sikander Azam · 2020 · Journal of Molecular Liquids
21. Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases
    Zhiqiang An · 2010 · Protein & Cell
22. COVID-19: Immunology, Immunopathogenesis and Potential Therapies
    Asha Bhardwaj, Leena Sapra, Chaman Saini, Zaffar Azam, Pradyumna Kumar Mishra, Bhupendra Verma, Gyan C. Mishra, Rupesh Kumar Srivastava · 2021 · International Reviews of Immunology
23. Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model
    Qiang Li, Hideyuki Ujiie, Akihiko Shibaki, Gang Wang, Reine Moriuchi, Hong-jiang Qiao, Hiroshi Morioka, Satoru Shinkuma, Ken Natsuga, Heather Ann Long et al. · 2010 · The Journal of Immunology
24. Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC Polyomaviruses
    John M. Lindner, Vanessa Cornacchione, Atul Sathe, Celine Be, Honnappa Srinivas, Elodie Riquet, Xavier Charles Leber, Andreas E. Hein, Matthias B. Wrobel, Meike Scharenberg et al. · 2019 · Immunity
25. Rapid production of antigen-specific monoclonal antibodies from a variety of animals
    Nobuyuki Kurosawa, Megumi Yoshioka, Rika Fujimoto, Fuminori Yamagishi, Masaharu Isobe · 2012 · BMC Biology
26. Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus
    Stefanie Iskra, Markus Kalla, Henri‐Jacques Delecluse, Wolfgang Hammerschmidt, Andreas Moosmann · 2010 · Journal of Virology
27. The advent and rise of monoclonal antibodies
    Klaus Rajewsky · 2019 · Nature
28. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
    Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, Fabio Benigni, Jiayi Zhou, Laura E. Rosen, Julia Noack, Fabrizia Zatta, Hannah Kaiser, Siro Bianchi et al. · 2023 · Journal of Hepatology
29. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
    Ralph A. Tripp, Lia M. Haynes, Deborah D. Moore, Barbara C. Anderson, Azaibi Tamin, Brian H. Harcourt, Les P. Jones, Mamadi Yilla, Gregory J. Babcock, Thomas C. Greenough et al. · 2005 · Journal of Virological Methods
30. Coronaviruses and their therapy
    Bart L. Haagmans, Albert D. M. E. Osterhaus · 2006 · Antiviral Research
31. Mining human antibody repertoires
    Roger R. Beerli, Christoph M. Rader · 2010 · mAbs
32. The auto-antigen repertoire in myasthenia gravis
    Kathleen Vrolix, Judith Fraussen, Peter C. Molenaar, Mario H. Losen, Veerle A Somers, Piet Stinissen, Marc H. De Baets, Pilar Martínez‐Martínez · 2010 · Autoimmunity
33. Is there a role for childhood vaccination against COVID‐19?
    Christiane Sigrid Eberhardt, Claire‐Anne Siegrist · 2020 · Pediatric Allergy and Immunology
34. Vaccines for the future: learning from human immunology
    Ennio De Gregorio, Rino Rappuoli · 2011 · Microbial Biotechnology
35. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
    Patrick C. Y. Woo, Susanna K. P. Lau, Hoi-Wah Tsoi, Zhiwei Chen, Beatrice H. L. Wong, Linqi Zhang, Jim K.H. Chan, Lei-po Wong, Wei He, Chi Ma et al. · 2005 · Vaccine
36. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor
    Kathleen Vrolix, Judith Fraussen, Mario H. Losen, Jo Stevens, Konstantinos Lazaridis, Peter C. Molenaar, Veerle A Somers, María Alma Bracho, Rozen Le Panse, Piet Stinissen et al. · 2014 · Journal of Autoimmunity
37. Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
    Tommy Richard Sun-wing Tong · 2009 · Infectious Disorders - Drug Targets
38. Monoclonal antibodies: From magic bullet to precision weapon
    Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, Lina M. Ismail, Adham Ezz El-Regal Mahmoud, Walid Faisal Elkhatib, Heba Aboul-Ella · 2024 · Molecular Biomedicine
39. Efficient cell pairing in droplets using dual-color sorting
    Hongxing Hu, David Eustace, Christoph A. Merten · 2015 · Lab on a Chip
40. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease
    M. Nazmul Hoque, Abed Chaudhury, Md. Abdul Mannan Akanda, M. Anwar Hossain, Tofazzal Islam · 2020 · PeerJ
41. Novel therapeutic approaches for treatment of COVID-19
    Nikoo Hossein‐Khannazer, Bahare Shokoohian, Anastasia I. Shpichka, Hamid Asadzadeh Aghdaei, Peter S. Timashev, Massoud Vosough · 2020 · Journal of Molecular Medicine
42. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
    Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, Ali Adili, Shadi Ghoreishizadeh, Hossein Saeedi, Lakshmi Prasanth Thangavelu, Navid Shomali, Ramin Aslaminabad, Faroogh Marofi et al. · 2022 · Cell Communication and Signaling
43. Human Antibodies for Viral Infections
    James E. Crowe · 2022 · Annual Review of Immunology
44. Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome
    Mitchell M. Levy, Melisse S. Baylor, Gordon R. Bernard, Rob A. Fowler, Teri J. Franks, Frederick G. Hayden, Rita F. Helfand, Stephen E. Lapinsky, Thomas R. Martin, Michael S. Niederman et al. · 2005 · American Journal of Respiratory and Critical Care Medicine
45. Stable long‐term cultures of self‐renewing B cells and their applications
    Mark J. Kwakkenbos, Pauline M. van Helden, Tim Beaumont, Hergen Spits · 2016 · Immunological Reviews
46. Monoclonal Antibody Therapeutics for Infectious Diseases: Beyond Normal Human Immunoglobulin
    Ryota Otsubo, Teruhito Yasui · 2022 · Pharmacology & Therapeutics
47. Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
    Michela Flego, Alessandro Ascione, Maurizio Cianfriglia, Stefano Vella · 2013 · BMC Medicine
48. Rapid isolation of antigen-specific antibody-secreting cells using a chip-based immunospot array
    Aishun Jin, Tatsuhiko Ozawa, Kazuto Tajiri, Tsutomu Obata, Hiroyuki Kishi, Atsushi Muraguchi · 2011 · Nature Protocols
49. Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
    Ponraj Prabakaran, Zhongyu Zhu, Xiaodong Xiao, Arya Biragyn, Antony S. Dimitrov, Christopher C. Broder, Dimiter Stanchev Dimitrov · 2009 · Expert Opinion on Biological Therapy
50. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
    Byoung-Shik Shim, Konrad Stadler, Huan Huu Nguyen, Cheol‐Heui Yun, Dong Wook Kim, Jun Chang, Cecil C. Czerkinsky, Manki Song · 2012 · Virology Journal
51. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis
    Abdelwahid Saeed Ali, Mubarak Mohammed Al-Shraim, Ahmed M. Al‐Hakami, Ian Martin Jones · 2015 · The Open Virology Journal
52. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
    Ritsuko Kubota‐Koketsu, Hiroyuki Mizuta, Masatoshi Oshita, Shoji Ideno, Mikihiro Yunoki, Motoki Kuhara, Naomasa Yamamoto, Yoshinobu Okuno, Kazuyoshi Ikuta · 2009 · Biochemical and Biophysical Research Communications
53. Expansion of Polyreactive B Cells Cross-Reactive to HLA and Self in the Blood of a Patient With Kidney Graft Rejection
    Fabrice Porcheray, Julie DeVito, Ynes A. Helou, Ian Dargon, J.W. Fraser, P. Nobecourt, Jack Ferdman, Sharon K. Germana, Timothy C. Girouard, T. Kawai et al. · 2012 · American Journal of Transplantation
54. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines
    Qingyong Ng, Fang He, Jimmy Kwang · 2015 · Viruses
55. Human monoclonal antibodies as candidate therapeutics against emerging viruses
    Yujia Jin, Cheng Lei, Dan Hu, Dimiter Stanchev Dimitrov, Tianlei Ying · 2017 · Frontiers of Medicine
56. Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
    Matthew McCallum, Young‐Jun Park, Cameron Stewart, Kaitlin R. Sprouse, Amin Addetia, Jack T Brown, M. Alejandra Tortorici, Cecily A. Gibson, Emily Wong, Margareta M. Ieven et al. · 2024 · Cell
57. From Whole Monoclonal Antibodies to Single Domain Antibodies: Think Small
    Jean‐Luc Teillaud · 2012 · Methods in molecular biology
58. Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma Cells
    Davide Corti, Antonio Lanzavecchia · 2014 · Microbiology Spectrum
59. Identifying Epitopes Responsible for Neutralizing Antibody and DC-SIGN Binding on the Spike Glycoprotein of the Severe Acute Respiratory Syndrome Coronavirus
    Yi-Ping Shih, Chia‐Yen Chen, Shih‐Jen Liu, Kuan-Hsuan Chen, Yuan-Ming Lee, Yu‐Chan Chao, Yi‐Ming Arthur Chen · 2006 · Journal of Virology
60. Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody
    Xiaoli Xiong, Davide Corti, Junfeng Liu, Debora Pinna, Mathilde Foglierini, Lesley J. Calder, Stephen R. Martin, Yi Pu Lin, P.A. Walker, Patrick J. Collins et al. · 2015 · Proceedings of the National Academy of Sciences
61. Antibodies against viruses: passive and active immunization
    Mansun Law, Lars Hangartner · 2008 · Current Opinion in Immunology
62. Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis
    Zhaochun Chen, Stanislav V. Sosnovtsev, Karin Bok, Gabriel Ignacio Parra, Michelle A. Makiya, Liane Agulto, Kim Y. Green, Robert H. Purcell · 2013 · Journal of Virology
63. Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein
    Roger R. Beerli, Monika Bauer, Nicole Schmitz, Regula B. Buser, Myriam Gwerder, Simone Muntwiler, Wolfgang A. Renner, Philippe Saudan, Martin F. Bachmann · 2009 · Virology Journal
64. DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
    Sarah T. C. Elliott, Nicole L. Kallewaard, Ebony Benjamin, Leslie Wachter-Rosati, Josephine M. McAuliffe, Ami R. Patel, Trevor R.F. Smith, Katherine Schultheis, Daniel H. Park, Seleeke Flingai et al. · 2017 · npj Vaccines
65. B cell characterization and reactivity analysis in multiple sclerosis
    Judith Fraussen, Kathleen Vrolix, Pilar Martínez‐Martínez, Mario H. Losen, Marc H. De Baets, Piet Stinissen, Veerle A Somers · 2009 · Autoimmunity Reviews
66. Severe Acute Respiratory Syndrome (SARS)
    Malik J. S. Peiris · 2003 · Journal of Clinical Virology
67. Ebanga™: The most recent FDA-approved drug for treating Ebola
    Elahe Taki, Roya Ghanavati, Tahereh Navidifar, Shirin Dashtbin, Mohsen Heidary, Marjan Moghadamnia · 2023 · Frontiers in Pharmacology
68. Monoclonal and recombinant antibodies, 30 years after …
    Emmanuelle Laffly, Régis Sodoyer · 2006 · Human Antibodies
69. Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis
    Zhaochun Chen, Konstantin Chumakov, Eugenia M. Dragunsky, Diana V. Kouiavskaia, Michelle A. Makiya, Alexander Neverov, Gennady V. Rezapkin, Andrew Sebrell, Robert H. Purcell · 2011 · Journal of Virology
70. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
    Yoshimi Enose‐Akahata, Anna Abrams, Raya Massoud, Izabela Bialuk, Kory R. Johnson, Patrick L. Green, Elizabeth M. Maloney, Steven Jacobson · 2013 · Retrovirology
71. Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection
    Katy A. Lloyd, Johanna Stéen, Khaled Amara, Philip J. Titcombe, Lena Israelsson, Susanna L. Lundström, Diana Zhou, Roman A. Zubarev, Evan Reed, Luca Piccoli et al. · 2018 · European Journal of Immunology
72. Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine
    Yu Min Kang, Dohsik Minn, Jaegyun Lim, Ki-Deok Lee, Dong Ho Jo, Kang Won Choe, Moon Jung Kim, Jong Min Kim, Kwang Nam Kim · 2021 · Journal of Korean Medical Science
73. The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly
    Helen Baxendale, Sheila Marie Keating, Marina Johnson, Jo Southern, Elizabeth Miller, David Goldblatt · 2010 · Vaccine
74. The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs
    Monica M Schaller, Monique Vogel, Karim Kentouche, Bernhard Lämmle, Johanna A. Kremer Hovinga · 2014 · Blood
75. Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines
    Lanying Du, Yuxian He, Yijia Wang, Haojie Zhang, Selene Ma, Charlotte K. L. Wong, Sharon Wu, Fai Ng, Jian‐Dong Huang, Kwok‐Yung Yuen et al. · 2006 · Virology
76. Immunotherapy of Alzheimer's disease (AD): From murine models to anti-amyloid beta (Aβ) human monoclonal antibodies
    Valeria Geylis, Michael O Steinitz · 2005 · Autoimmunity Reviews
77. SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
    Thomas J. Vogl, Sigal Leviatan, Eran Segal · 2021 · Cell Reports Medicine
78. A highly potent antibody effective against SARS-CoV-2 variants of concern
    Craig W. Fenwick, Priscilla Turelli, Laurent H. Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, Jérémy Campos, Erica Lana, Flurin Fiscalini, Charlène Raclot et al. · 2021 · Cell Reports
79. Antibody-guided structure-based vaccines
    Peter D. Kwong, Brandon J. DeKosky, Jeffrey B. Ulmer · 2020 · Seminars in Immunology
80. Cell‐microarray analysis of antigen‐specific B‐cells: Single cell analysis of antigen receptor expression and specificity
    Kazuto Tajiri, Hiroyuki Kishi, Yoshiharu Tokimitsu, Sachiko Kondo, Tatsuhiko Ozawa, Koshi Kinoshita, Aishun Jin, Shinichi Kadowaki, Toshiro Sugiyama, Atsushi Muraguchi · 2007 · Cytometry Part A
81. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
    Tianlei Ying, Haoyang Li, Lu Lu, Dimiter Stanchev Dimitrov, Shibo Jiang · 2014 · Microbes and Infection
82. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development
    Eliana Gisela Acosta, Ralf F. W. Bartenschlager · 2015 · Expert Review of Vaccines
83. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
    Tommy Richard Sun-wing Tong · 2006 · Perspectives in medical virology
84. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach
    Christine Tkaczyk, Srinath Kasturirangan, Andrea Minola, Omari Jones-Nelson, von Minckwitz Gunter, Yuru Shi, Kim Rosenthal, Vineela Aleti, Е. А. Семенова, Paul Warrener et al. · 2017 · Antimicrobial Agents and Chemotherapy
85. Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone
    Julie E. Pickett, John M. Thompson, Agnieszka Sadowska, Christine Tkaczyk, Bret R. Sellman, Andrea Minola, Davide Corti, Antonio Lanzavecchia, Lloyd S. Miller, Daniel L.J. Thorek · 2018 · Bone Research
86. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
    Sean Pinney, Gennaro Giustino, Jonathan L. Halperin, Jeffrey Ian Mechanick, Eric Neibart, Jeffrey W. Olin, Robert S. Rosenson, Valentı́n Fuster · 2020 · Journal of the American College of Cardiology
87. Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus
    Zhe Chen, Jianmin Wang, Linlin Bao, Li Guo, Weijia Zhang, Ying Xue, Hongli Zhou, Yan Xiao, Jianwei Wang, Fan Wu et al. · 2015 · Nature Communications
88. Characterization of severe acute respiratory syndrome coronavirus membrane protein
    Daniel Voß, Anika Kern, Elisabetta Traggiai, Markus Eickmann, Konrad Stadler, Antonio Lanzavecchia, Stephan Becker · 2006 · FEBS Letters
89. Autoantibodies in cancer: prognostic biomarkers and immune activation
    Kerstin Järås, Karen S. Anderson · 2011 · Expert Review of Proteomics
90. Application of Microbial Genomic Science to Advanced Therapeutics
    Claire M. Fraser, Rino Rappuoli · 2004 · Annual Review of Medicine
91. Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice
    Smita Jaiswal, Kenneth Smith, Alejandro Ramirez, Marcia Woda, Pamela Pazoles, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm, Anuja Mathew · 2014 · Experimental Biology and Medicine
92. Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
    Tohru Miyoshi‐Akiyama, I. Ishida, Masaya Fukushi, Keina Yamaguchi, Yusuke Matsuoka, Takashi Ishihara, Masayoshi Tsukahara, Seisuke Hatakeyama, Norikazu Itoh, Aki Morisawa et al. · 2011 · The Journal of Infectious Diseases
93. Interferon-inducer antivirals: Potential candidates to combat COVID-19
    Ashkan Bagheri, Seyed Mohammad Iman Moezzi, Pouria Mosaddeghi, Sadra Nadimi Parashkouhi, Seyed Mostafa Fazel Hoseini, Fatemeh Badakhshan, Manica Negahdaripour · 2020 · International Immunopharmacology
94. Regulation of PfEMP1–VAR2CSA translation by a Plasmodium translation-enhancing factor
    Sherwin Chun-Leung Chan, Alejandra Frasch, Chandra Sekhar Mandava, Jun-Hong Ch’ng, María del Pilar Quintana, Mattias Vesterlund, Mehdi Ghorbal, Nicolas Joannin, Oscar Franzén, José-Juan Lopez-Rubio et al. · 2017 · Nature Microbiology
95. Solid-Phase Microextraction of DNA from Mycobacteria in Artificial Sputum Samples To Enable Visual Detection Using Isothermal Amplification
    Marcelino Varona, Xiong Ding, Kevin D. Clark, Jared L. Anderson · 2018 · Analytical Chemistry
96. Immune activation suppresses initiation of lytic Epstein-Barr virus infection
    Kristin Ladell, Marcus Dorner, Ludwig Zauner, Christoph Berger, Franziska Zucol, Michele Bernasconi, Felix K Niggli, Roberto F. Speck, David Nadal · 2007 · Cellular Microbiology
97. Mapping epitopes and antigenicity by site-directed masking
    Didrik Paus, Greg P. Winter · 2006 · Proceedings of the National Academy of Sciences
98. Epitope Specificity Determines Pathogenicity and Detectability of Anti–Platelet‐Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis
    Gianluca Moroncini, Antonella Grieco, Giulia Nacci, Chiara Paolini, Cecilia Tonnini, Katarzyna N. Pozniak, Massimiliano Cuccioloni, Matteo Mozzicafreddo, Silvia Svegliati, Mauro Angeletti et al. · 2015 · Arthritis & Rheumatology
99. Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?
    Korakrit Poonsuk, Luis Gabriel Gimenez-Lirola, Jianqiang Zhang, Paolo Arruda, Qi Chen, Lucas Correa da Silva Carrion, Ronaldo L. Magtoto, Pablo Enrique Piñeyro, Luciana V. Sarmento, Chong Wang et al. · 2016 · PLoS ONE
100. Passive Immunization
     Mark K. Slifka, Ian J. Amanna · 2017 · Elsevier eBooks